GoodCell Competitors

Our Mission: To provide the highest-quality stem cell preservation service and care to our patients, families, and their physicians. We at ViaCord believe these words are much more than just a promise. They are the commitment we live by. Our Origins: ViaCord was established in 1993 to give expectant parents an opportunity to bank their children's cord blood with comfort and security. Prior to launching our Cord Blood Banking Service, ViaCord conducted extensive research and validation studies to set high standards regarding the collection, processing, and storage of cord blood. ViaCord worked closely with the following institutions during our development: * Obstetrics Program at Brigham and Women's Hospital in Boston, MA * The Christ Hospital in Cincinnati, OH * The University of Cincinnati's Hoxworth Blood Center, OH ViaCord's headquarters are located in Cambridge, Massachusetts; a recognized global hub of biotechnology. All cord blood collections are processed and stored at our cord blood storage facility outside of Cincinnati.

Founded over 20 years ago in the UK, Future Health has become one of the world's largest family biobanks. With quality and accessibility at the heart of what we do, we have supported over 100,000 families in their quest to help safeguard their children's future through stem cell banking. Extensive investment and innovation have allowed us to expand our service offering to include complementary in-house laboratory screening and genomics services. As a highly regarded and accredited biobank we are also trusted by world-renowned research institutions and hospitals to store samples on their behalf.

Americord is a leader in the advancement of umbilical cord blood, cord tissue, and placental tissue banking. As a private bank, Americord collects, processes, and stores newborn stem cells for future medical or therapeutic use by the family that saves them. Americord is committed to pioneering the development of new cord blood banking technologies. Under the direction of its Executive Medical Director, Dr. Robert Dracker, the company developed Cord Blood 2.0, a proprietary collection and extraction process that can harvest up to twice as many stem cells compared to a traditional cord blood collection. Based in New York, Americord is registered with the FDA and operates in all 50 states. The company’s laboratory is accredited by the AABB and complies with all federal and state guidelines and applicable licenses. Our Promises The highest quality stem cell preservation products and services in the industry A proven commitment to pioneering innovations that help families today and tomorrow The most value for your investment in cutting-edge medical options for your child and family